Omoyinmi E, Melo Gomes S, Standing A, et al. Brief report: whole‐exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheumatol 2014; 66:197.895 895. Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum 2011; 63:3625.
896 896. Nagendran S, Richards AJ, McNinch A, et al. Somatic mosaicism and the phenotype expression of COL2A1 mutations. Am J Med Genet A 2012; 158A:1204.
897 897. Meguro T, Yoshida Y, Hayashi M, et al. Inheritance of polyalanine expansion mutation of PHOX2B in congenital central hypoventilation syndrome. J Hum Genet 2012; 57:335.
898 898. Ng BG, Buckingham KJ, Raymond K, et al. Mosaicism of the UDP‐galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet 2013; 92:632.
899 899. Kurek KC, Luks VL, Ayturk UM, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90:1108.
900 900. Baquero‐Montoya C, Gil‐Rodríguez MC, Braunholz D, et al. Somatic mosaicism in a Cornelia de Lange syndrome patient with NIPBL mutation identified by different next generation sequencing approaches. Clin Genet 2014; 86:595.
901 901. Girisha KM, Lewis LE, Phadke SR, et al. Costello syndrome with severe cutis laxa and mosaic HRAS G12S mutation. Am J Med Genet A 2010; 152A:2861.
902 902. Alzualde A, Moreno F, Martinez‐Lage P, et al. Somatic mosaicism in a case of apparently sporadic Creutzfeldt‐Jakob disease carrying a de novo D178n mutation in the PRNP gene. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1283.
903 903. Goriely A, Lord H, Lim J, et al. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: implications for genetic testing in “paternal age‐effect” syndromes. Am J Med Genet A 2010; 152:2067.
904 904. Zampatti S, Mela J, Peconi C, et al. Identification of Duchene/Becker muscular dystrophy mosaic carriers through a combined DNA/RNA analysis. Prenat Diagn 2018; 38(13):1096.
905 905. Filho AB, Souza J, Faucz FR, et al. Somatic/gonadal mosaicism in a syndromic form of ectrodactyly, including eye abnormalities, documented through array‐based comparative genomic hybridization. Am J Med Genet A 2011; 155A:1152.
906 906. Bourdeaut F, Hérault A, Gentien D, et al. Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabomyosarcoma. J Med Genet 2010; 47:859.
907 907. Terracciano A, Specchio N, Darra F, et al. Somatic mosaicism of PCDH19 mutation in a family with low‐penetrance EFMR. Neurogenetics 2012; 13:341.
908 908. Dibbens LM, Kneen R, Bayly MA, et al. Recurrence risk of epilepsy and mental retardation in females due to parental mosaicism of PCDH19 mutations. Neurology 2011; 76:1514.
909 909. Maclellan RA, Luks VL, Vivero MP, et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg 2014; 133:12e.
910 910. Jansen AC, Oostra A, Desprechins B, et al. TUBA1A mutations: from isolated lissencephaly to familial polymicrogyria. Neurology 2011; 76:988.
911 911. Pinto FO, Leblanc T, Chamousset D, et al. Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica 2009; 94:487.
912 912. Li X, Jiang M, Han W, et al. A novel TNNI2 mutation causes Freeman‐Sheldon syndrome in a Chinese family with an affected adult with only facial contractures. Gene 2013; 527:630.
913 913. Filipe B, Albuquerque Q, Bik E, et al. APC somatic mosaicism in a patient with Gardner syndrome carrying the E1573X mutation: report of a case. Dis Colon Rectum 2009; 52:1516.
914 914. Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K‐AKT3‐mTOR pathway cause of hemi‐megalencephaly. Nat Genet 2012; 44:941.
915 915. Eyries M, Coulet F, Girerd B, et al. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension. Clin Genet 2012; 82:173.
916 916. Pastrello C, Fornasarig M, Pin E, et al. Somatic mosaicism in a patient with Lynch syndrome. Am J Med Genet A 2009; 149A:212.
917 917. Hsu AP, Sowerwine KJ, Lawrence MG, et al. Intermediate phenotypes in patients with autosomal dominant hyper‐IgE syndrome caused by somatic mosaicism. J Allergy Clin Immunol 2013; 131:1586.
918 918. Rabin R, Millan F, Cabrera‐Luque J, et al. Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent. Am J Med Genet A 2018; 176(12):2907.
919 919. Tsubahara M, Hayashi Y, Niijima S, et al. Isolated growth hormone deficiency in two siblings because of paternal mosaicism for a mutation in the GH1 gene. Clin Endocrinol (Oxf) 2012; 76:420.
920 920. Doisaki S, Muramatsu H, Shimada A, et al. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia. Blood 2012; 120:1485.
921 921. Hafner C, Toll A, Gantner S, et al. Keratinocyte epidermal nevi are associated with mosaic RAS mutations. J Med Genet 2012; 49:249.
922 922. Prochazkova K, Pavlikova K, Minarik M, et al. Somatic TP53 mosaicism in a patient with Li‐Fraumeni syndrome. Am J Med Genet A 2009; 149A:206.
923 923. Thibodeau IL, Xu J, Li Q, et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43‐deletion mutant identified from atrial tissue. Circulation 2010; 122:236.
924 924. Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43:1262.
925 925. Vissers LE, Fano V, Martinelli D, et al. Whole‐exome sequencing detects somatic mutations of IDH1 in metaphyseal chondromatosis with D‐2‐hydroxyglutaric aciduria (MC‐HGA). Am J Med Genet A 2011; 155A:2609.
926 926. Odgerel Z, Sarkozy A, Lee HS, et al. Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation. Neuromuscul Disord 2010; 20:438.
927 927. Catalli C, Morgante A, Iraci R, et al. Validation of sensitivity and specificity of tetraplet‐primed PCR (TP‐PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2). J Mol Diagn 2010; 12:601.
928 928. Marini M, Bocciardi R, Gimelli S, et al. A spectrum of LMX1B mutations in Nail‐Patella syndrome: new point mutations, deletion, and evidence of mosaicism in unaffected parents. Genet Med 2010; 12:431.
929 929. Messiaen L, Vogt J, Bengesser K, et al. Mosaic type‐1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type‐1 (NF1). Hum Mutat 2011; 32:213.
930 930. Goutagny S, Bah AB, Parfait B, et al. Neurofibromatosis type 2 in the elderly population: clinical and molecular features. Am J Med Genet A 2013; 161A:667.
931 931. Saitsu H, Hoshino H, Kato M, et al. Paternal mosaicism of an STXBP1 mutation in OS. Clin Genet 2011; 80:484.
932 932. Szuhai K, Jennes I, de Jong D, et al. Tiling resolution array‐CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum Mutat 2011; 32:e2063.
933 933.
